authorized the Chairman to final the relevant details, documentations, and/or actions for Over-allotment Agreement and/or CCPT-KY IPO Plan as deem appropriate. The IPO Plan and the Optional Shares will dilute
- - 4.4 0.1 - - Revenue from service under a Power Purchase Agreement 407.4 35.7 396.1 35.1 1,232.8 36.3 1,118.6 34.3 Adder 30.8 2.7 30.6 2.7 94.5 2.8 94.6 2.9 Revenue from waste management 10.4 0.9 10.1
% 4,586.4 5,315.9 729.5 15.9% Revenue from finance lease under power purchase agreement 99.2 101.6 104.9 105.3 0.4 0.4% 401.2 411.0 9.8 2.4% Revenue from construction under a concession arrangement
borrowing and lending It shall disclose the materiality of transaction briefly, namely objective of transaction, category of securities purchased under resale agreement and borrowing and lending securities
Securities sold under repurchase agreement, securities purchased under resale agreement and securities borrowing and lending It shall disclose the materiality of transaction briefly, namely objective of
shall disclose the materiality of transaction briefly, namely objective of transaction, category of securities purchased under resale agreement and borrowing and lending securities, category of received
acquisition transaction was subject to the approval from the meeting of the shareholders and upon certain conditions precedent under the share purchase agreement have been fulfilled. Currently, the status of
Characteristics of the Transaction: The company will purchase 100% of the ordinary shares of Modern Pharma Company Limited in accordance to the agreement in the Share Purchase Agreement. Prior to proceeding with
any facts that are material. 3. Opinions of the independent expert on the entering into the transaction The Company has appointed Capital Advantage Company Limited as the independent financial advisor